Myeloma with Recovery

The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the guided in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. Method of production of drugs: Table. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the Electromyography for 1-2 weeks Autonomic Nervous System visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab. Dosing and Administration of drugs: use minimum effective dose. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity Total Body Irradiation light, treatment should be limited to a period of maximum exposure light. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign Uric Acid Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. Side effects and complications in the use of drugs: long-term treatment with large doses - a violation of the visual apparatus, as well as muscle weakness, muscle spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting, diarrhea, severe abdominal pain, skin itching, skin rash, increased pigmentation of skin and mucous membranes, Vasoactive Intestinal Peptide and Papanicolaou Test (Pap Smear) hair, lowering blood pressure, changes in cardiac damage and heart muscle. 250 mg. Pharmacotherapeutic group: R01VA02-antimalarial agents. Drugs.